Kadans has exchanged contracts to buy Oxford Biomedica's
Windrush Court in Oxford for £60m. Completion is due to occur on or around 18 November 2022. The sale proceeds will exceed the
target offer figure of £55m. The current
Thank you for reading EG
Want to read more? Enjoy a story a week for FREE for one month.
Register
Find Out More